Search

Aciclovir Injection IP 250 mg (ACICLOVIN-250 INJECTION)

ACICLOVIN-250 contains Aciclovir 250 mg Lyophilized Powder for Intravenous Infusion I.P., indicated for the treatment of severe herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections. Manufactured in a WHO-GMP certified pharmaceutical facility with assured quality standards. Ready stock available. Order now for bulk supply and distribution.

ACICLOVIN-250 (Aciclovir Injection IP 250 mg)

ACICLOVIN-250 is a premium quality Aciclovir Intravenous Infusion I.P. 250 mg formulated as a lyophilized powder for slow intravenous infusion after dilution. It is widely prescribed for the treatment of serious viral infections caused by Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), including herpes encephalitis, neonatal herpes, severe genital herpes, and shingles in immunocompromised patients.

Manufactured in a WHO-GMP Certified pharmaceutical manufacturing plant, ACICLOVIN-250 is produced under stringent quality control standards to ensure safety, efficacy, and consistency.

Key Features

  • Aciclovir Injection I.P. 250 mg
  • Lyophilized Powder for IV Infusion
  • High-quality sterile formulation
  • WHO-GMP Certified Manufacturing Facility
  • Suitable for hospital and institutional supply
  • Bulk quantities available
  • Ready Stock Available
  • Third Party Manufacturing Available

Order Now!
We offer reliable bulk supply, institutional supply, government tender support, exports, and third-party manufacturing services from our WHO-GMP certified manufacturing facility.

Content missing

Scroll to Top